Recombinant IL6 (Clazakizumab Biosimilar) antibody

Catalog No. ABIN7829267

The Humanized Monoclonal anti-IL6 (Clazakizumab Biosimilar) antibody is suitable to detect IL6 (Clazakizumab Biosimilar) in samples from Human. It has been validated for ELISA.

Quick Overview for Recombinant IL6 (Clazakizumab Biosimilar) antibody (ABIN7829267)

Target: IL6 (Clazakizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This IL6 (Clazakizumab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-IL6 (Clazakizumab Biosimilar) Antibody

Purpose: Anti-IL6(clazakizumab biosimilar) mAb

Isotype: IgG1, K214R, N297A, kappa

Application Details

Application Notes: ELISA 1:5000-10000

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Please see Certificate of Analysis for specific instructions of reconstitution.

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for IL6 (Clazakizumab Biosimilar)

Target: IL6 (Clazakizumab Biosimilar)

Alternative Name: Clazakizumab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:IFNB2, IL-6
Synonyms Antibody:ALD-518,BMS-945429

UniProt: P05231